# Combination of Danazole With Berberine in the Treatment of ITP

> **NCT03909763** · PHASE2 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 55 (actual)

## Conditions studied

- Corticosteroid-resistant or Relapsed ITP

## Interventions

- **DRUG:** Berberine plus danazol

## Key facts

- **NCT ID:** NCT03909763
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-20
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2020-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909763, "Combination of Danazole With Berberine in the Treatment of ITP". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03909763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*